Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication

Clinical and Experimental Immunology

Volumn 107, Issue 2, 1997, Pages 293-299

  Orendi, J M ^a,d   Verheul, A F M ^a   De Vos, N M ^a   Visser, M R ^a   Snippe, H ^a   Cherniak, R ^b   Vaishnav, V V ^b   Rijkers, G T ^c   Verhoef, J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GEORGIA STATE UNIVERSITY   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

cryptococcus; HIV; mannoprotein; MHC class II; monoclonal antibody

Indexed keywords

GLUCURONOXYLOMANNAN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOPROTEIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CRYPTOCOCCUS NEOFORMANS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0031033387     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.283-ce1169.x     Document Type: Article

References (48)

1. Miller GG, Puck J. In vitro human lymphocyte responses to Cryptococcus neofomons. Evidence for primary and secondary responses in normals and infected subjects. J Immunol 1984; 133:166-72.
2. Mody CH, Syme RM. Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans. Infect Immun 1993; 61:464-9.
3. Vecchiarelli A, Dottorini M, Pietrella D, Monari C, Retini C, Todisco T, Bistoni F. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. Am J Respir Cell Mol Biol 1994; 11:130-7.
4. Margolick JB, Volkman DJ, Folks TM, Fauci AS. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. J Immunol 1987; 138:1719-23.
5. Tong-Starksen SE, Luciw PA, Peterlin BM. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol 1989; 142:702-7.
6. Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990; 9:1551-60.
7. Pantaleo G, Graziosi C, Demarest JF et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362:355-8.
8. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz, K, Haase AT. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993; 362:359-62.
9. Lu W, Israel-Biet D. Virion concentration in bronchoalveolar lavage fluids of HIV infected patients. Lancet 1993; 342:298.
10. Ho DD. HIV-1 viremia and influenza. Lancet 1992; 339:1549.
11. Wallis RS, Vjecha M, Tahmasseb MA et al. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta-2-microglobulin in HIV-1 associated tuberculosis. J Infect Dis 1993; 167:43-48.
12. Zhang Y, Nakata K, Weiden M, Rom WN. Mycorobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J Clin Invest 1995; 95:2324-31.
13. + lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acq Immun Def Synd 1995; 8:386-91.
14. Orendi JM, Nottet HSLM, Visser MR, Verheul AFM, Snippe H, Verhoef J. Enhancement of HIV-1 replication in peripheral blood mononuclear cells by Cryptococcus neoformans is monocyte-dependent but tumour necrosis factor-independent. AIDS 1994; 8:423-9.
15. Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun 1994; 62:1507-12.
16. Koning F, Schreuder GMT, Bontrop R, Vries P, Giphart MJ, Bruning JW. A monoclonal antibody with MT2 specificity. Disease Markers 1984; 2:75.
17. Koning F, Raghoebar J, Schreuder GMT, Schuurman R, Bruning H. A monoclonal antibody detecting an HLA-DQw1 related determinant. Tissue Antigens 1985; 26:100-9.
18. van Horssen M, Loman S, Rijkers GT, Boom SE, Bloem AC. Coligation of ICAM-1 (CD54) and membrane IgM negatively affects B cell receptor signaling. Eur J Immunol 1995; 25:154-8.
19. Ahsmann EJ, Lokhorst HM, Dekker AW, Bloem AC. Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood 1992; 79:2068-75.
20. Koning F, Kardol M, Bruning H. Antibody dependent cellular cytotoxicity mediated by HLA-class II specific monoclonal antibodies. Tissue Antigens 1986; 28:170-5.
21. Cherniak R, Reiss E, Turner SH. A galactoxylomannan antigen of Cryptococcus neoformans serotype A. Carbohydr Res 1982; 103:239-50.
22. Turner SH, Cherniak R, Reiss E. Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr Res 1984; 125:343-9.
23. James PG, Cherniak R. Galactoxylomannans of Cryptococcus neoformans. Infect Immun 1992; 60:1084-8.
24. Peterson PK, Sharp BM, Gekker G, Portoghese PS, Sannerud K, Balfour HH. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 1990; 4:869-73.
25. Japour AJ, Mayers DL, Johnson VA et al. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. Antimicrob Agents Chemother 1993; 37:1095-101.
26. Armitage P, Berry G. In: Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1987.
27. Boyd AW, Wawryk SO, Burns GF, Fecondo JV. Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. Proc Natl Acad Sci USA 1988; 85:3095-9.
28. Hoy JF, Murphy JW, Miller GG. T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection. J Infect Dis 1989; 159:116-9.
29. Pettoello-Mantovani M, Casadevall A, Kollmann TR, Rubinstein A, Goldstein H. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet 1992; 339:21-23.
30. Ishioka GY, Lamont AG, Thomson D, Bulbow N, Gaeta FC, Sette A, Grey HM. MHC interaction and T cell recognition of carbohydrates and glycopeptides. J Immunol 1992; 148:2446-51.
31. Bellamy A, Davison AN, Feldmann M. Derivation of ganglioside-specific T cell lines of suppressor or helper phenotype from cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 1986; 12:107-20.
32. Henningsson CM, Selvaraj S, MacLean GD, Suresh MR, Noujaim AA, Longenecker BM. T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo. Cancer Immunol Immunother 1987; 25:231-41.
33. Jackson S, Folks TM, Wetterskog DL, Kindt TJ. A rabbit helper T cell clone reactive against group-specific streptococcal carbohydrate. J Immunol 1984; 133:1553.
34. Moll H, Mitchell GF, McConville MJ, Handman E, Evidence for T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major. Infect Immun 1989; 57:3349.
35. Katsuki M, Kakimoto K, Kawata S, Kotani S, Koga T. Induction of delayed-type hypersensitivity by the T cell line specific to bacterial peptidoglycans. J Immunol 1987; 139:3570-2.
36. Peeters CC. Tenbergen Meekes AM, Heijnen CJ, Poolman JT, Zegers BJ, Rijkers GT. In vitro activation of human T lymphocytes by Haemophilus influenzae type b capsular polysaccharides. Scand J Immunol 1992; 35:137-48.
37. Emmrich F. Do carbohydrate antigens stimulate human T cells? Review article, APMIS 1990; 98:1-8.
38. Manca F, Newell A, Valle M, Habeshaw J, Dalgleish AG. HIV-induced deletion of antigen-specific T cell function is MHC restricted. Clin Exp Immunol 1992; 87:15-19.
39. Kalter DC, Gendelman HE, Meltzer MS. Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules. Immunol Letters 1991; 30:219-27.
40. Vermot Desroches C, Rigal D, Escaich S, Bernaud J, Pichoud C, Lamelin JP, Trepo C. Functional epitope analysis of the human CD1 la/CD18 molecule (LFA-1. lymphocyte function-associated antigen 1) involved in HIV-1-induced syncytium formation. Scand J Immunol 1991; 34:461-70.
41. Diegel ML, Moran PA, Gilliland LK, Damle NK, Hayden MS, Zarling JM, Ledbetter JA. Regulation of HIV production by blood mononuclear cells from HIV-infected donors: II. HIV-1 production depends on T cell-monocyte interaction. AIDS Res Hum Retrovir 1993; 9:465-73.
42. Cheynier R, Henrichwark S, Hadida F, Pelletier E, Oksenhendler E, Autran B, Wain Hobson S. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 1994; 78:373-87.
43. Knight SC. AIDS. A problem of antigen presentation? Curr Biol 1994; 4:1131-4.
44. Knight SC, Macatonia SE. Effect of HIV on antigen presentation by dendritic cells and macrophages. Res Virol 1991; 142:123-8.
45. Pinchuk LM, Polacino PS, Agy MB, Klaus SJ, Clark EA. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1994; 1:317-25.
46. Levitz SM, Tabuni A, Kornfeld H, Reardon CC, Golenbock DT. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun 1994; 62:1975-81.
47. Matsuyama T, Kobayashi N, Yamamoto N, Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991; 5:1405-17.
48. Peterson PK, Gekker G, Chao CC, Hu S, Edelman C, Balfour HH, Verhoef J. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrossis factor-α-mediated mechanism. J Clin Invest 1992; 89:574-80.